(Q40597491)

English

Phase IB study on prevention of surgery-induced immunodeficiency with preoperative administration of low-dose subcutaneous interleukin-2 in gastric cancer patients

scientific article published on September 2001

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Phase IB study on prevention of surgery-induced immunodeficiency with preoperative administration of low-dose subcutaneous interleukin-2 in gastric cancer patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

author name string

Cerea K

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Romano F

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Bravo AF

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Motta V

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Uggeri F

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Brivio F

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Fumagalli LA

7

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Uggeri F

8

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

publication date

1 September 2001

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Journal of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

78

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

32-37

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Decreased interleukin-2 production in patients with gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.1120

21 January 2018

Prognostic significance of peripheral lymphocyte counts and carcinoembryonic antigens in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJSO.1120

21 January 2018

Lymphocyte subsets as prognostic markers for cancer patients receiving immunomodulative therapy

1 reference

https://api.crossref.org/works/10.1002%2FJSO.1120

21 January 2018

Association of a Circulating Immunosuppressive Polypeptide with Operative and Accidental Trauma

1 reference

https://api.crossref.org/works/10.1002%2FJSO.1120

21 January 2018

Surgery, Trauma and Immune Suppression Evolving the Mechanism

1 reference

https://api.crossref.org/works/10.1002%2FJSO.1120

21 January 2018

Subcutaneous administration of interleukin-2 in human immunodeficiency virus type 1-infected persons

1 reference

https://api.crossref.org/works/10.1002%2FJSO.1120

21 January 2018

Redistribution of lymphocytes after major surgical stress.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.1120

21 January 2018

In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1002%2FJSO.1120

21 January 2018

The interleukin-2 T-cell system: a new cell growth model.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.1120

21 January 2018

Lower survival in metastatic cancer patients with reduced interleukin-2 blood concentrations. Preliminary report

1 reference

https://api.crossref.org/works/10.1002%2FJSO.1120

21 January 2018

Soluble interleukin-2 receptor, CD4 and CD8 levels in melanoma: a longitudinal study

1 reference

https://api.crossref.org/works/10.1002%2FJSO.1120

21 January 2018

Studies in prognostic factors relating to chemotherapy for advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.1120

21 January 2018

Phase-II randomized study of pre-operative IL-2 administration in operable NSCLC

1 reference

https://api.crossref.org/works/10.1002%2FJSO.1120

21 January 2018

Preoperative interleukin-2 subcutaneous immunotherapy may prolong the survival time in advanced colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FJSO.1120

21 January 2018

Extended lymph node dissection for gastric cancer: results of a prospective, multi-centre analysis of morbidity and mortality in 118 consecutive cases

1 reference

https://api.crossref.org/works/10.1002%2FJSO.1120

21 January 2018

Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1002%2FJSO.1120

21 January 2018

Identifiers

10.1002/JSO.1120

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40597491&oldid=1903511111"